GADD45A and chronic myelogenous leukemia, BCR-ABL1 positive: Research has found that GADD45A expression is upregulated in samples from patients with chronic myeloid leukemia (CML) in the chronic phase, but downregulated in the accelerated and blast phases, which correlates with the severity of the disease, and low expression predicts a poorer prognosis.